Osteoclasts play a part in pain due to the inflammation adjacent to bone

被引:166
作者
Nagae, Maho
Hiraga, Toru
Wakabayashi, Hiroki
Wang, Liyang
Iwata, Koichi
Yoneda, Toshiyuki
机构
[1] Osaka Univ, Grad Sch Dent, Dept Biochem, Suita, Osaka 5650871, Japan
[2] Nihon Univ, Sch Dent, Dept Physiol, Chiyoda Ku, Tokyo 1018310, Japan
[3] Nihon Univ, Sch Dent, Dent Res Ctr, Div Funct Morphol,Chiyoda Ku, Tokyo 1018310, Japan
关键词
hyperalgesia; bisphosphonates; osteoclasts; proton; acid-sensing receptors; MEDULLARY DORSAL-HORN; FOS-LIKE PROTEIN; TEMPOROMANDIBULAR-JOINT; PERSISTENT HYPERALGESIA; MOLECULAR-MECHANISMS; NOXIOUS-STIMULATION; NEURONAL-ACTIVITY; SKELETAL PAIN; SPINAL-CORD; CELL-LINE;
D O I
10.1016/j.bone.2006.04.033
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Bone disorders with increased osteoclastic bone resorption are frequently associated with bone pain and inhibitors of osteoclasts reduce bone pain. Osteoclasts degrade bone minerals by secreting protons through the vacuolar H+-ATPase, creating acidic microenvironments. Because acidosis is a well-known cause of pain, we reasoned that osteoclasts cause pain through proton secretion. We explored this using an animal model in which a single subcutaneous injection of the complete Freund's adjuvant (CFA) in the hind-paw caused inflammatory hyperalgesia (hyperresponsiveness to noxious stimuli). Osteoclastic bone resorption was increased in the metatarsal bones in the CFA-injected hind-paws. CFA-induced hyperalgesia was significantly suppressed by the bisphosphonates, zoledronic acid (ZOL) and alendronate and osteoprotegerin. c-src-deficient mice in which osteoclasts are inherently dysfunctional exhibited reduced CFA-induced hyperalgesia. Repeated subcutaneous injections of parathyroid hormone-related protein into the hind-paw also induced hyperalgesia with increased osteoclastic bone resorption. The hyperalgesia was associated with increased mRNA expression of acid-sensing ion channel (ASIC) 1a, 1b and 3 in the ipsi-lateral dorsal root ganglions (DRGs) by RT-PCR and c-Fos in the ipsi-lateral spinal dorsal horn by immunohistochemistry. Of note, ZOL decreased the ASIC1a mRNA expression and c-Fos. Treatment of the DRG cell line F-11 with acid (pH5.5) increased ASIC1a, 1b and 3 mRNA expression and nuclear c-Fos expression. The ASIC blocker amiloride inhibited acid-induced c-Fos expression in F-11 cells. Moreover, F-11 cells transfected with the transient receptor potential channel vanilloid subfamily member 1 (TRPV1) showed increased acid-induced nuclear c-Fos expression compared with parental F-11 cells. Finally, bafilomycin A I, an inhibitor of the vacuolar H+-ATPase, reversed the hyperalgesia and down-regulated ASIC1a mRNA expression in the DRGs. These results led us to propose that osteoclasts play a part in CFA-induced inflammatory pain through an activation of the acid-sensing receptors including ASICs and TRPV1 by creating acidosis. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1107 / 1115
页数:9
相关论文
共 46 条
[1]
Adami S, 2002, CLIN EXP RHEUMATOL, V20, P55
[2]
Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta [J].
Åström, E ;
Söderhäll, S .
ARCHIVES OF DISEASE IN CHILDHOOD, 2002, 86 (05) :356-364
[3]
REQUIREMENT OF PP60C-SRC EXPRESSION FOR OSTEOCLASTS TO FORM RUFFLED BORDERS AND RESORB BONE IN MICE [J].
BOYCE, BF ;
YONEDA, T ;
LOWE, C ;
SORIANO, P ;
MUNDY, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (04) :1622-1627
[4]
EXPRESSION OF C-FOS-LIKE PROTEIN AS A MARKER FOR NEURONAL-ACTIVITY FOLLOWING NOXIOUS-STIMULATION IN THE RAT [J].
BULLITT, E .
JOURNAL OF COMPARATIVE NEUROLOGY, 1990, 296 (04) :517-530
[5]
The capsaicin receptor: a heat-activated ion channel in the pain pathway [J].
Caterina, MJ ;
Schumacher, MA ;
Tominaga, M ;
Rosen, TA ;
Levine, JD ;
Julius, D .
NATURE, 1997, 389 (6653) :816-824
[6]
DAVIES J, 1979, CANCER TREAT REP, V63, P1835
[7]
NEUROCHEMICAL CHARACTERISTICS OF A NOVEL DORSAL-ROOT GANGLION X NEUROBLASTOMA HYBRID CELL-LINE, F-11 [J].
FRANCEL, PC ;
HARRIS, K ;
SMITH, M ;
FISHMAN, MC ;
DAWSON, G ;
MILLER, RJ .
JOURNAL OF NEUROCHEMISTRY, 1987, 48 (05) :1624-1631
[8]
The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials [J].
Fulfaro, F ;
Casuccio, A ;
Ticozzi, C ;
Ripamonti, C .
PAIN, 1998, 78 (03) :157-169
[9]
Analgesic effect of intravenous pamidronate on chronic back pain due to osteoporotic vertebral fractures [J].
Gangji, V ;
Appelboom, T .
CLINICAL RHEUMATOLOGY, 1999, 18 (03) :266-267
[10]
USE OF CALCITONIN IN THE TREATMENT OF BONE PAIN ASSOCIATED WITH OSTEOPOROSIS [J].
GENNARI, C ;
AGNUSDEI, D ;
CAMPOREALE, A .
CALCIFIED TISSUE INTERNATIONAL, 1991, 49 :S9-S13